Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

IF 3.1 4区医学 Q1 ECONOMICS

Applied Health Economics and Health Policy Pub Date : 2024-07-12 DOI:10.1007/s40258-024-00900-5

Oscar Espinosa, Paul Rodríguez-Lesmes, Giancarlo Romano, Esteban Orozco, Sergio Basto, Diego Ávila, Lorena Mesa, Hernán Enríquez

{"title":"Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges","authors":"Oscar Espinosa, Paul Rodríguez-Lesmes, Giancarlo Romano, Esteban Orozco, Sergio Basto, Diego Ávila, Lorena Mesa, Hernán Enríquez","doi":"10.1007/s40258-024-00900-5","DOIUrl":null,"url":null,"abstract":"<div><p>The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.</p></div>","PeriodicalId":8065,"journal":{"name":"Applied Health Economics and Health Policy","volume":"22 6","pages":"797 - 804"},"PeriodicalIF":3.1000,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s40258-024-00900-5.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Health Economics and Health Policy","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s40258-024-00900-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}

引用次数: 0

Abstract

The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies, coverage, and price regulation of health technologies in nine countries. We investigated whether countries used cost-effectiveness thresholds for public health policy decision making and found that few countries have adopted the cost-effectiveness threshold as an official criterion for financing, reimbursement, or pricing. However, in countries where it is applied, such as Thailand, the results have been very favorable in terms of minimizing health technology prices and ensuring the financial sustainability of the health system. Although the cost-effectiveness threshold has opportunities for improvement, particularly in certain institutional contexts and with adequate participation of the different strategic actors in the formulation of public policy, its potential use and added value are significant in various aspects.

查看原文本刊更多论文

在医疗保健公共政策中使用成本效益阈值：进展与挑战》。

文章比较分析了成本效益阈值在九个国家卫生技术的融资政策、覆盖范围和价格监管决策过程中的影响。我们调查了各国是否在公共卫生政策决策中使用成本效益阈值，发现很少有国家将成本效益阈值作为融资、报销或定价的官方标准。然而，在泰国等采用成本效益阈值的国家，在最大限度地降低医疗技术价格和确保医疗系统的财务可持续性方面取得了非常好的效果。尽管成本效益阈值还有改进的余地，特别是在某些体制背景下，以及在不同战略行动者充分参与公共政策制定的情况下，但其潜在用途和附加值在各个方面都具有重要意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Applied Health Economics and Health Policy Economics, Econometrics and Finance-Economics and Econometrics

CiteScore

6.10

自引率

2.80%

发文量

期刊介绍： Applied Health Economics and Health Policy provides timely publication of cutting-edge research and expert opinion from this increasingly important field, making it a vital resource for payers, providers and researchers alike. The journal includes high quality economic research and reviews of all aspects of healthcare from various perspectives and countries, designed to communicate the latest applied information in health economics and health policy. While emphasis is placed on information with practical applications, a strong basis of underlying scientific rigor is maintained.